Pharmaserv AG

Primary packaging of pharmaceutical active ingredients in solid powder form according to current Good Manufacturing Practice (cGMP) and Good Distribution Practice (cGDP).

Company undergoes bi-annual inspection by Swiss Institute for Therapeutic Products (Swissmedic) and operates under cGMP/cGDP standards.

Downloadable PDF price lists available with and without controlled substances (latter requires login). Includes Top 20 products and partner brand pricing.

Large selection of products available from stock (ab Lager) for immediate shipment.

Complimentary shipping on reorders and replenishment shipments.

Operating locations in Stansstad, Switzerland (CH-6362) and Bangkok, Thailand for international distribution.

Orders placed before 15:00 hours are delivered the next day via A-Post. Monday to Saturday shipping.

Small-scale confectioning (primary packaging) of pharmaceutical active ingredients according to GMP standards, tailored for pharmacy and hospital needs.

Supply products in gram quantities with no minimum order quantity or minimum order value. Serves small customers and enterprises with flexible ordering.

Favorable payment terms available for customers who stock inventory, allowing payment at extended intervals (e.g., 3-month terms for 3-month supply).

E-commerce cart system with comparison features and wishlist management.

My-Account area for managing login, preferences, and accessing controlled substances pricing.

Online access to controlled substances and narcotics (Betäubungsmittel) available through verified login with company approval for authorized recipients.

Extensive range of active pharmaceutical ingredients from qualified suppliers and manufacturers, including products from multiple proprietary brands.

All deliveries comply with Good Distribution Practice (GDP) standards. Shipments up to 5kg are delivered in GDP cooling boxes. Return labels for cooling boxes included in shipping cost.

Gebindeweise Garantierung der Identität (GID) - container-wise identity guarantee of raw materials according to Ph. Helv. 20.1.6.4. Includes full specification analysis per pharmacopoeia standards, exempting qualified pharmacists and hospitals from mandatory goods identity testing upon receipt.

Access to competent specialists for consultation on sourcing substances and technical product information.